Empresa Boston Therapeutics, Inc. Other OTC
Acciones
BTHE
US1011501004
Equipo médico y tecnología avanzada
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
David Ludvigson
CEO | Chief Executive Officer | 74 | - |
Director of Finance/CFO | - | 19/01/23 | |
Bradley Johnson
CTO | Chief Tech/Sci/R&D Officer | - | 01/11/22 |
Vidur Sahney
COO | Chief Operating Officer | - | 31/03/22 |
John Hardesky
PRN | Corporate Officer/Principal | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Jerry Fiddler
BRD | Director/Board Member | 72 | - |
Chairman | 69 | - | |
David Ludvigson
CEO | Chief Executive Officer | 74 | - |
Director/Board Member | 67 | - | |
Tadd Lazarus
BRD | Director/Board Member | - | 31/08/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 0 | 540 | 0 | 0 | 42,05 % |
Acción B | 0 | 377 | 0 | 0 | |
Acción C | 1 | 48 996 763 | 20 604 326 ( 42,05 %) | 0 |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+35,76 % | 8820,43 M | |
+40,57 % | 4587,94 M | |
-30,31 % | 2639,83 M | |
-10,39 % | 1586,65 M | |
-21,90 % | 1349,69 M | |
-37,12 % | 1076,13 M | |
+2,95 % | 921 M | |
-42,75 % | 799 M | |
-23,01 % | 677 M |